机构:[1]Department of Cardiothoracic Surgery, Peking Union Medical College, Tsinghua University, Beijing, China[2]Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, & Peking Union Medical College, Beijing,100730, China[3]Department of Cardiothoracic Surgery, Jiangsu Academy of Clinical Medical Sciences, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China外科系统胸外科江苏省人民医院[4]Division of Congenital Heart Surgery, Department of Pediatric Cardiothoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China外科系统胸外科江苏省人民医院[5]Cardiac Intensive Care Unit, Department of Pediatric Cardiothoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China外科系统胸外科江苏省人民医院[6]Echocardiography Laboratory, Department of Pediatric Cardiothoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China外科系统胸外科江苏省人民医院[7]Paul C Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China[8]Department of Cardiovascular Surgery, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China临床科室心脏外科中心血管科首都医科大学附属安贞医院[9]Ministry of Education Key Laboratory of Clinical Laboratory Diagnostics, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China
Background Robust evidence is lacking regarding the clinical efficacy, safety and cardiopulmonary performance of perventricular closure. This study investigated the perioperative efficacy, safety and cardiorespiratory performance of perventricular closure of perimembranous ventricular septal defects (pmVSDs). Methods Operation-naive infants and young children aged 5-60 months with isolated pmVSDs were randomised to receive either standard open surgical or minimally invasive perventricular closure via direct entry into the ventricle with a catheter from a subxiphoid incision. The primary outcomes included complete closure at discharge, major and minor adverse events and the changes in perioperative cardiorespiratory performance from baseline. Complete closure was mainly analysed in the modified intention-to-treat (mITT) population, with sensitivity analyses for the ITT, per-protocol (PP) and as-treated (AT) populations (non-inferiority margin -5.0%). Results We recruited 200 patients with pmVSDs for this study (mean age 24.38 months, range 7-58 months, 104 girls), of whom 100 were randomly allocated to one of the study groups. The non-inferiority of perventricular to surgical closure regarding complete closure at discharge was not shown in the ITT (absolute difference -0.010 (95% CI -0.078 to 0.058)) and mITT populations (-0.010 (95% CI -0.069 to 0.048)), but was shown in the PP (0.010 (95% CI -0.043 to 0.062)) and AT populations (0.048 (95% CI -0.009 to 0.106)). Perventricular closure reduced the rate of compromising cardiac haemodynamics, electrophysiological responses, cardiomyocyte viability, respiratory mechanics, ventilatory and gas exchange function and oxygenation and tissue perfusion compared with surgical closure (all between-group P<0.05). Conclusions For infants and young children with pmVSD, perventricular closure reduced the rate of postoperative cardiorespiratory compromise compared with surgical closure, but the non-inferiority regarding complete closure should be interpreted in the context of the specific population.
基金:
Innovation Patents Program of State Intellectual Property Office of China [CN104091094A, CN104091062A]; Graduate Practice Innovation Program of Jiangsu Higher Schools [SJZZ20140118]; Priority Academic Development Program of Jiangsu Higher Education Institutions [JX10231081]; Innovation Award of Jiangsu Med-Tech Introduction [JPH-2014035]; National Clinical Key Specialty Construction Projects of China; National Natural Science Foundation of China [81571701]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|2 区医学
小类|2 区心脏和心血管系统
最新[2025]版:
大类|2 区医学
小类|2 区心脏和心血管系统
第一作者:
第一作者机构:[1]Department of Cardiothoracic Surgery, Peking Union Medical College, Tsinghua University, Beijing, China[2]Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, & Peking Union Medical College, Beijing,100730, China[3]Department of Cardiothoracic Surgery, Jiangsu Academy of Clinical Medical Sciences, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China[4]Division of Congenital Heart Surgery, Department of Pediatric Cardiothoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
共同第一作者:
通讯作者:
通讯机构:[2]Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, & Peking Union Medical College, Beijing,100730, China
推荐引用方式(GB/T 7714):
Liu Hong,Lu Feng-xia,Zhou Jie,et al.Minimally invasive perventricular versus open surgical ventricular septal defect closure in infants and children: a randomised clinical trial[J].HEART.2018,104(24):2035-2043.doi:10.1136/heartjnl-2017-312793.
APA:
Liu, Hong,Lu, Feng-xia,Zhou, Jie,Yan, Fei,Qian, Si-chong...&Liu, Xiao-cheng.(2018).Minimally invasive perventricular versus open surgical ventricular septal defect closure in infants and children: a randomised clinical trial.HEART,104,(24)
MLA:
Liu, Hong,et al."Minimally invasive perventricular versus open surgical ventricular septal defect closure in infants and children: a randomised clinical trial".HEART 104..24(2018):2035-2043